Literature DB >> 22368527

Generic antiepileptic drugs: how good is close enough?

Barry E Gidal.   

Abstract

Year:  2012        PMID： 22368527      PMCID： PMC3280470          DOI： 10.5698/1535-7511-12.1.32

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  7 in total

1.  Assessing bioequivalence of generic antiepilepsy drugs.

Authors:  Gregory L Krauss; Brian Caffo; Yi-Ting Chang; Craig W Hendrix; Kelly Chuang
Journal:  Ann Neurol       Date:  2011-06-29       Impact factor: 10.422

2.  Generic antiepileptic drugs and associated medical resource utilization in the United States.

Authors:  D M Labiner; P E Paradis; R Manjunath; M S Duh; M-H Lafeuille; D Latrémouille-Viau; P Lefebvre; S L Helmers
Journal:  Neurology       Date:  2010-04-14       Impact factor: 9.910

Review 3.  The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.

Authors:  Mei Sheng Duh; Kevin E Cahill; Pierre Emmanuel Paradis; Pierre Y Cremieux; Paul E Greenberg
Journal:  Expert Opin Pharmacother       Date:  2009-10       Impact factor: 3.889

4.  Generic antiepileptic drugs: current controversies and future directions.

Authors:  Michael D Privitera
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

5.  Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.

Authors:  M J Berg; R A Gross; K J Tomaszewski; W M Zingaro; L S Haskins
Journal:  Neurology       Date:  2008-08-12       Impact factor: 9.910

Review 6.  Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Margaret R Stedman; Ellen J Bubrick; Joshua J Gagne; Alexander S Misono; Joy L Lee; M Alan Brookhart; Jerry Avorn; William H Shrank
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

7.  The risks and costs of multiple-generic substitution of topiramate.

Authors:  M S Duh; P E Paradis; D Latrémouille-Viau; P E Greenberg; S P Lee; M B Durkin; G J Wan; M F T Rupnow; J LeLorier
Journal:  Neurology       Date:  2009-06-16       Impact factor: 9.910
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.